Research & Publications
A curated library of peer-reviewed studies, systematic reviews, and meta-analyses supporting stem cell and exosome-based therapies across neurological, orthopaedic, metabolic, and other conditions — all sourced from PubMed / PubMed Central.
Systematic Reviews
Meta-Analyses
Clinical Trial Evidence
Neurological Conditions
Parkinson’s Disease
Stem Cell Therapy for Parkinson’s Disease — Systematic Review & Meta-Analysis (2023)
A systematic review and meta-analysis pooling outcomes across clinical trials of cell-based therapies for Parkinson’s disease. It found preliminary evidence of benefit — particularly in patients who still respond to levodopa — while noting that more high-quality trials are needed.
Cerebral Palsy
Efficacy and Safety of Stem Cell Therapy in Cerebral Palsy — Systematic Review & Meta-Analysis (2022)
A systematic review and meta-analysis pooling trial results for stem cell therapy in children with cerebral palsy. Results showed improved motor function scores at 3, 6, and 12 months with no significant difference in adverse events versus controls.
Spinal Cord Injury · Multiple Sclerosis · Ischaemic Stroke
MSC Safety and Clinical Efficacy Across Three Neurological Conditions (2022)
A systematic review evaluating the safety and clinical efficacy of mesenchymal stem cell treatment across traumatic spinal cord injury, multiple sclerosis, and ischaemic stroke — finding a generally favourable safety profile while noting that efficacy varied by condition.
Orthopaedic & Musculoskeletal Conditions
Knee & Joint Osteoarthritis
MSC-Based Therapy for Osteoarthritis — Systematic Review & Meta-Analysis (2026)
A systematic review and meta-analysis assessing mesenchymal stem cell-based therapy for osteoarthritis, pooling functional outcome and pain data across included trials.
Metabolic & Wound-Healing Conditions
Diabetic Foot Ulcers
Autologous Stem Cells for Diabetic Foot Ulcers — Meta-Analysis
A meta-analysis examining autologous stem cell treatment for diabetic foot ulcers, pooling wound-healing outcomes relevant to reducing amputation risk in patients with severe peripheral vascular disease or neuropathy.
Exosome Therapy — Emerging Evidence
Exosome — Multi-Condition
Exosome-Based Drug Delivery: A Next-Generation Platform Across Multiple Conditions
A broad review covering exosome-based drug delivery as an emerging platform across cancer, infectious disease, neurological and immunological conditions, gene therapy, and regenerative medicine — outlining the current science and future therapeutic potential.
Have Questions About Your Condition?
Our medical team reviews every case individually. Share your reports and we will let you know whether stem cell or exosome therapy may be appropriate for your situation.
Content reviewed by qualified members of our medical team | Last updated: June 2026
